Gaudium IVF And Women Health (NSE:GAUDIUMIVF) Notes Receivable: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GAUDIUMIVF Gaudium IVF And Women Health Ltd NSE:GAUDIUMIVF
20 GF Score
Price ₹143.78
! 5 Warning Signs
View Full Analysis

What is Gaudium IVF And Women Health Notes Receivable?

Gaudium IVF And Women Health NSE:GAUDIUMIVF +4.99% 20 Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

Gaudium IVF And Women Health's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Gaudium IVF And Women Health Notes Receivable Related Terms

Gaudium IVF And Women Health Notes Receivable Historical Data

* Premium members only.

The historical data trend for Gaudium IVF And Women Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gaudium IVF And Women Health Notes Receivable Chart

Gaudium IVF And Women Health Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Gaudium IVF And Women Health Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:GAUDIUMIVF
20GF Score
Gaudium IVF And Women Health Ltd NSE:GAUDIUMIVF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gaudium IVF And Women Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a Notes Receivable of ₹0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Gaudium IVF And Women Health and its competitors.
Is Gaudium IVF And Women Health's Notes Receivable too high?
Gaudium IVF And Women Health's current Notes Receivable is ₹0.0 Mil. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's Notes Receivable compare to HCA and THC?
Gaudium IVF And Women Health's Notes Receivable of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Gaudium IVF And Women Health and its competitors. Gaudium IVF And Women Health's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gaudium IVF And Women Health Business Description

Other Exchanges 544709:India
Address B1/51, Janak Puri, B-1, Near Janakpuri East Metro Station, New Delhi, IND, 110058
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score

Get the complete analysis for NSE:GAUDIUMIVF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹143.78
Price